Adenosine A2A receptor deficient mice are partially resistant to limbic seizures

被引:54
|
作者
El Yacoubi, Malika [1 ]
Ledent, Catherine [2 ]
Parmentier, Marc [2 ]
Costentin, Jean [1 ]
Vaugeois, Jean-Marie [1 ]
机构
[1] UFR Med & Pharm, CNRS, Unite Neuropsychopharmacol Expt, FRE 2735,IFRMP 23, F-76183 Rouen, France
[2] Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium
关键词
A(2A) receptor knockout mice; Pentylenetetrazol; Pilocarpine; Kindling; Convulsants; TEMPORAL-LOBE EPILEPSY; PENTYLENETETRAZOL-INDUCED SEIZURES; LONG-TERM TREATMENT; ENDOGENOUS ADENOSINE; STATUS-EPILEPTICUS; GLUTAMATE RELEASE; RAT HIPPOCAMPUS; NERVE-TERMINALS; BRAIN-DAMAGE; MOUSE-BRAIN;
D O I
10.1007/s00210-009-0426-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The neuromodulator adenosine, acting through activation of four defined metabotropic receptors called A(1), A(2A), A(2B) and A(3,) has been proposed as an endogenous anticonvulsant. Here, the consequences of deleting the adenosine A(2A) receptor have been examined in different experimental models of epilepsy. A(2A)R KO mice were not protected against seizures originating from brainstem structures, namely electroshock-induced seizures. The intensities of seizures induced by pentylenetetrazol or pilocarpine, as well as the percentages of convulsing mice, were significantly reduced in A(2A) receptor knockout (A(2A)R KO) animals. A(2A)R KO mice exhibited reduced pentylenetetrazol-induced kindled seizures, demonstrating an important role of the A(2A) receptor in the acquisition of kindling. These data suggest that adenosine stimulating A(2A) receptors modulates excitatory neurotransmission and exacerbates limbic seizures. It is therefore suggested that adenosine A(2A) receptor antagonists might offer protection from some epileptic syndromes.
引用
收藏
页码:223 / 232
页数:10
相关论文
共 50 条
  • [31] Characterisation of central adenosine A1 receptors and adenosine transporters in mice lacking the adenosine A2a receptor
    Snell, BJ
    Short, JL
    Drago, J
    Ledent, C
    Lawrence, AJ
    BRAIN RESEARCH, 2000, 877 (02) : 160 - 169
  • [32] Caffeine Neuroprotection Decreases A2A Adenosine Receptor Content in Aged Mice
    Michelle Lima Garcez
    Adriani Paganini Damiani
    Robson Pacheco
    Lucas Rodrigues
    Larissa Letieli de Abreu
    Márcio Correa Alves
    Vanessa Moraes de Andrade
    Carina Rodrigues Boeck
    Neurochemical Research, 2019, 44 : 787 - 795
  • [33] GABAergic involvement in motor effects of an adenosine A2A receptor agonist in mice
    Khisti, RT
    Chopde, CT
    Abraham, E
    NEUROPHARMACOLOGY, 2000, 39 (06) : 1004 - 1015
  • [34] Adenosine A2A Receptor Deletion Blocks the Beneficial Effects of Lactobacillus reuteri in Regulatory T-Deficient Scurfy Mice
    He, Baokun
    Hoang, Thomas K.
    Tran, Dat Q.
    Rhoads, Jon Marc
    Liu, Yuying
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [35] IMPAIRED PLACENTAL VESSEL FORMATION IN MICE LACKING OF ADENOSINE A2A RECEPTOR
    Rojas, Daniela
    Acurio, Jesenia
    Troncos, Felipe
    Herlitz, Kurt
    Covarrubias, Ambart
    Aguayo, Claudio
    Lara, Evelyn
    Escudero, Carlos
    PLACENTA, 2019, 83 : E20 - E20
  • [36] Adenosine A2A receptor deletion enhances neointimal formation from arterial injury in apolipoprotein-E deficient mice
    Wang, H
    Tang, R
    Chen, JF
    Linden, J
    Huo, YQ
    FASEB JOURNAL, 2006, 20 (04): : A729 - A729
  • [37] Changes in spinal δ and κ opioid systems in mice deficient in the A2A receptor gene
    Bailey, A
    Ledent, C
    Kelly, M
    Hourani, SMO
    Kitchen, I
    JOURNAL OF NEUROSCIENCE, 2002, 22 (21): : 9210 - 9220
  • [38] Adenosine deaminase as an allosteric modulator of A2A adenosine receptor
    Gracia Sanchez, Eduardo
    Cortes Tejedor, Antonio
    Moreno Guillen, Estefania
    Bakesova, Jana
    Perez-Capote, Kamil
    Mallol Montero, Josefa
    Canela Campos, Enric I.
    Franco Fernandez, Rafael
    Lluis Biset, Carmen
    Casado Burillo, Vicent
    PURINERGIC SIGNALLING, 2010, 6 : 45 - 46
  • [39] Selective adenosine A2A receptor antagonists
    Ongini, E
    Monopoli, A
    Cacciari, B
    Baraldi, PG
    FARMACO, 2001, 56 (1-2): : 87 - 90
  • [40] Adenosine Receptor A2a Polymorphisms and Caffeine
    Geraci, Marilla B.
    Luckenbaugh, David A.
    Gorodetsky, Elena
    Ernst, Monique
    Goldman, David
    Pine, Daniel
    BIOLOGICAL PSYCHIATRY, 2011, 69 (09) : 58S - 58S